| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.917 | 0.001 | 0.917 | Nav1.1 sodium channel blocker | 0.47 0.004 CID_53463653 | ||
| 0.817 | 0.004 | 0.817 | Anticonvulsant | 0.507 0.012 CID_53463653 | ||
| 0.577 | 0.003 | 0.577 | Tumour necrosis factor antagonist | |||
| 0.52 | 0.011 | 0.52 | Superoxide dismutase inhibitor | |||
| 0.472 | 0.037 | 0.472 | Aldehyde oxidase inhibitor | |||
| 0.413 | 0.004 | 0.413 | Alcohol dehydrogenase inhibitor | 0.236 0.009 CID_53463653 | ||
| 0.412 | 0.007 | 0.412 | Interleukin 6 antagonist | 0.314 0.013 CID_53463653 | ||
| 0.389 | 0.003 | 0.389 | Liver X receptor agonist | 0.087 0.009 CID_53463653 | ||
| 0.375 | 0.008 | 0.375 | Nav1.2 sodium channel blocker | |||
| 0.405 | 0.055 | 0.405 | Thioredoxin glutathione reductase inhibitor | |||
| 0.333 | 0.005 | 0.333 | Nav1.6 sodium channel blocker | |||
| 0.42 | 0.094 | 0.42 | Beta lactamase inhibitor | |||
| 0.371 | 0.075 | 0.371 | GABA C receptor rho-3 antagonist | |||
| 0.303 | 0.009 | 0.303 | Nav1.3 sodium channel blocker | |||
| 0.32 | 0.028 | 0.427 | RNA-directed DNA polymerase inhibitor | 0.427 0.015 CID_53463653 | CID_53463653 | |
| 0.286 | 0.003 | 0.286 | Aggrecanase 1 inhibitor | |||
| 0.389 | 0.11 | 0.389 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.338 | 0.064 | 0.569 | Immunomodulator | 0.569 0.014 CID_53463653 | CID_53463653 | |
| 0.27 | 0.008 | 0.27 | DNA directed RNA polymerase inhibitor | 0.18 0.017 CID_53463653 | ||
| 0.289 | 0.036 | 0.289 | Anesthetic general | |||
| 0.298 | 0.054 | 0.298 | Tumour necrosis factor alpha release inhibitor | |||
| 0.269 | 0.052 | 0.269 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.261 | 0.043 | 0.385 | Peptidyltransferase inhibitor | 0.385 0.008 CID_53463653 | CID_53463653 | |
| 0.262 | 0.045 | 0.262 | Neuropeptide Y2 antagonist | |||
| 0.244 | 0.045 | 0.244 | Growth hormone agonist | |||
| 0.199 | 0.023 | 0.199 | Ferrochelatase inhibitor | |||
| 0.242 | 0.072 | 0.516 | DNA synthesis inhibitor | 0.516 0.012 CID_53463653 | CID_53463653 | |
| 0.237 | 0.07 | 0.415 | Cyclic AMP phosphodiesterase inhibitor | 0.415 0.014 CID_53463653 | CID_53463653 | |
| 0.171 | 0.005 | 0.171 | Macrophage elastase inhibitor | |||
| 0.193 | 0.033 | 0.193 | GABA C receptor rho-2 antagonist | |||
| 0.178 | 0.022 | 0.468 | UDP-glucose 4-epimerase inhibitor | 0.468 0.003 CID_53463653 | CID_53463653 | |
| 0.215 | 0.066 | 0.215 | Nitric-oxide synthase stimulant | |||
| 0.238 | 0.095 | 0.238 | 5 Hydroxytryptamine release stimulant | |||
| 0.231 | 0.103 | 0.231 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.153 | 0.026 | 0.37 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.37 0.004 CID_53463653 | CID_53463653 | |
| 0.118 | 0.004 | 0.118 | MDM2 inhibitor | |||
| 0.126 | 0.02 | 0.126 | HIV-1 reverse transcriptase inhibitor | 0.073 0.047 CID_53463653 | ||
| 0.154 | 0.053 | 0.161 | Alpha-N-acetylglucosaminidase inhibitor | 0.161 0.049 CID_53463653 | CID_53463653 | |
| 0.096 | 0.004 | 0.096 | Aggrecanase 2 inhibitor | |||
| 0.293 | 0.201 | 0.375 | Caspase 9 stimulant | 0.375 0.127 CID_53463653 | CID_53463653 | |
| 0.099 | 0.008 | 0.099 | Nicotinic acid receptor 1 agonist | |||
| 0.106 | 0.017 | 0.106 | Aldose reductase inhibitor | |||
| 0.102 | 0.017 | 0.102 | Secretase beta inhibitor | |||
| 0.101 | 0.018 | 0.216 | Biliverdin reductase inhibitor | 0.216 0.005 CID_53463653 | CID_53463653 | |
| 0.121 | 0.039 | 0.121 | GABA C receptor rho-1 antagonist | |||
| 0.097 | 0.016 | 0.097 | Androgen agonist | |||
| 0.083 | 0.005 | 0.083 | Pregnane X receptor antagonist | |||
| 0.14 | 0.062 | 0.14 | Sodium channel (voltage-gated) blocker | |||
| 0.083 | 0.006 | 0.083 | Nicotinic acid receptor agonist | |||
| 0.123 | 0.047 | 0.123 | GABA C receptor agonist | |||
| 0.082 | 0.01 | 0.082 | Kinesin antagonist | |||
| 0.082 | 0.01 | 0.082 | Kinesin-like protein 1 inhibitor | |||
| 0.161 | 0.091 | 0.17 | Lipocortins synthesis antagonist | 0.17 0.08 CID_53463653 | CID_53463653 | |
| 0.122 | 0.054 | 0.122 | 5 Hydroxytryptamine 3A agonist | |||
| 0.089 | 0.023 | 0.089 | Phospholipase D inhibitor | |||
| 0.078 | 0.012 | 0.078 | Dihydroorotate oxidase inhibitor | |||
| 0.1 | 0.038 | 0.1 | Metalloproteinase-2 inhibitor | |||
| 0.103 | 0.041 | 0.266 | NADH dehydrogenase inhibitor | 0.266 0.007 CID_53463653 | CID_53463653 | |
| 0.084 | 0.022 | 0.084 | Collagenase 3 inhibitor | |||
| 0.117 | 0.056 | 0.117 | GABA C receptor antagonist | |||
| 0.064 | 0.005 | 0.082 | Uridine phosphorylase inhibitor | 0.082 0.003 CID_53463653 | CID_53463653 | |
| 0.266 | 0.207 | 0.266 | 5 Hydroxytryptamine release inhibitor | |||
| 0.095 | 0.037 | 0.095 | Glycine receptor antagonist | |||
| 0.109 | 0.051 | 0.109 | Anabolic | 0.092 0.074 CID_53463653 | ||
| 0.106 | 0.049 | 0.106 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.091 | 0.037 | 0.091 | Metalloproteinase-9 inhibitor | |||
| 0.137 | 0.085 | 0.137 | Ca2+-transporting ATPase inhibitor | |||
| 0.073 | 0.022 | 0.073 | Phosphodiesterase 1A inhibitor | |||
| 0.174 | 0.124 | 0.174 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.051 | 0.004 | 0.051 | Nicotinic acid receptor 2 antagonist | |||
| 0.131 | 0.085 | 0.204 | Cell wall synthesis inhibitor | 0.204 0.028 CID_53463653 | CID_53463653 | |
| 0.073 | 0.028 | 0.225 | Argininosuccinate synthase inhibitor | 0.225 0.006 CID_53463653 | CID_53463653 | |
| 0.084 | 0.04 | 0.084 | Polo-like kinase-2 inhibitor | |||
| 0.058 | 0.014 | 0.058 | Liver X receptor alpha agonist | |||
| 0.058 | 0.014 | 0.072 | Thymidine kinase inhibitor | 0.072 0.01 CID_53463653 | CID_53463653 | |
| 0.05 | 0.01 | 0.05 | Liver X receptor beta agonist | |||
| 0.162 | 0.123 | 0.162 | Histone acetyltransferase inhibitor | |||
| 0.218 | 0.18 | 0.218 | Toll-Like receptor 7 agonist | |||
| 0.066 | 0.029 | 0.138 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.138 0.009 CID_53463653 | CID_53463653 | |
| 0.052 | 0.014 | 0.052 | Membrane dipeptidase inhibitor | |||
| 0.051 | 0.013 | 0.051 | Kainate receptor agonist | |||
| 0.098 | 0.061 | 0.098 | Electrolyte absorption antagonist | |||
| 0.048 | 0.011 | 0.048 | Calcitonin gene-related peptide antagonist | |||
| 0.075 | 0.04 | 0.075 | Matrix metalloproteinase inhibitor | |||
| 0.077 | 0.043 | 0.26 | Phosphofructokinase-1 inhibitor | 0.26 0.007 CID_53463653 | CID_53463653 | |
| 0.244 | 0.212 | 0.244 | Calcium channel L-type activator | |||
| 0.088 | 0.057 | 0.088 | Interleukin 5 antagonist | |||
| 0.043 | 0.013 | 0.043 | ADAM10 endopeptidase inhibitor | |||
| 0.214 | 0.185 | 0.214 | Toll-Like receptor agonist | |||
| 0.065 | 0.036 | 0.065 | Phosphodiesterase 1C inhibitor | |||
| 0.045 | 0.017 | 0.045 | Potassium channel Kv1.1 blocker | |||
| 0.06 | 0.033 | 0.06 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.035 | 0.008 | 0.035 | DNA polymerase III inhibitor | |||
| 0.078 | 0.051 | 0.078 | Keratolytic | |||
| 0.213 | 0.187 | 0.214 | Histamine release inhibitor | 0.214 0.186 CID_53463653 | CID_53463653 | |
| 0.065 | 0.039 | 0.138 | Carbamoyl phosphate synthetase inhibitor | 0.138 0.013 CID_53463653 | CID_53463653 | |
| 0.19 | 0.164 | 0.19 | Gastrin inhibitor | |||
| 0.115 | 0.09 | 0.115 | Sodium channel blocker | |||
| 0.034 | 0.009 | 0.034 | Thymidine phosphorylase inhibitor | 0.03 0.012 CID_53463653 | ||
| 0.069 | 0.044 | 0.069 | Acetylcholine M5 receptor agonist | |||
| 0.143 | 0.119 | 0.143 | Neurotensin receptor agonist | |||
| 0.042 | 0.019 | 0.042 | Nicotinic acid receptor 2 agonist | |||
| 0.032 | 0.009 | 0.042 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.042 0.005 CID_53463653 | CID_53463653 | |
| 0.087 | 0.064 | 0.087 | Phosphodiesterase I inhibitor | |||
| 0.068 | 0.045 | 0.068 | Glutamate (mGluR6) antagonist | |||
| 0.028 | 0.005 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 CID_53463653 | ||
| 0.145 | 0.123 | 0.145 | Succinate dehydrogenase inhibitor | |||
| 0.03 | 0.01 | 0.03 | Acid ceramidase inhibitor | |||
| 0.067 | 0.048 | 0.067 | Glutamate (mGluR7) antagonist | |||
| 0.119 | 0.1 | 0.119 | Peroxidase inhibitor | |||
| 0.089 | 0.071 | 0.089 | Phosphodiesterase 7B inhibitor | |||
| 0.089 | 0.073 | 0.089 | Creatine kinase inhibitor | |||
| 0.094 | 0.079 | 0.231 | Adenylate kinase inhibitor | 0.231 0.012 CID_53463653 | CID_53463653 | |
| 0.015 | 0.003 | 0.015 | DNA topoisomerase III inhibitor | |||
| 0.11 | 0.097 | 0.169 | DNA repair enzyme inhibitor | 0.169 0.018 CID_53463653 | CID_53463653 | |
| 0.019 | 0.008 | 0.019 | Thyroid hormone alpha agonist | |||
| 0.188 | 0.176 | 0.188 | Insulysin inhibitor | |||
| 0.138 | 0.127 | 0.16 | Psychostimulant | 0.16 0.108 CID_53463653 | CID_53463653 | |
| 0.016 | 0.005 | 0.016 | DNA polymerase III polC-type inhibitor | |||
| 0.061 | 0.051 | 0.061 | Phosphodiesterase III inhibitor | |||
| 0.056 | 0.048 | 0.056 | Phosphodiesterase 1B inhibitor | |||
| 0.193 | 0.186 | 0.455 | Antithrombotic | 0.455 0.037 CID_53463653 | CID_53463653 | |
| 0.056 | 0.05 | 0.056 | NMDA receptor glycine site agonist | |||
| 0.032 | 0.027 | 0.032 | Protein kinase (CK2) beta inhibitor | |||
| 0.039 | 0.036 | 0.039 | Angiotensin AT1 receptor antagonist | |||
| 0.049 | 0.047 | 0.049 | Alcohol oxidase inhibitor | |||
| 0.023 | 0.021 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.016 | 0.014 | 0.016 | Calcitonin gene-related peptide 1 receptor antagonist | |||
| 0.03 | 0.029 | 0.095 | Fumarate hydratase inhibitor | 0.095 0.006 CID_53463653 | CID_53463653 | |
| 0.03 | 0.03 | 0.055 | Purinergic P2Y2 antagonist | 0.055 0.009 CID_53463653 | CID_53463653 | |
| 0.121 | 0.123 | 0.139 | Adenylate cyclase stimulant | 0.139 0.083 CID_53463653 | CID_53463653 | |
| 0.043 | 0.047 | 0.1 | Ornithine carbamoyltransferase inhibitor | 0.1 0.016 CID_53463653 | CID_53463653 | |
| 0.007 | 0.018 | 0.015 | Purinergic P2Y2 agonist | 0.015 0.003 CID_53463653 | CID_53463653 | |
| 0.036 | 0.049 | 0.045 | Thymidylate synthase inhibitor | 0.045 0.035 CID_53463653 | CID_53463653 | |
| 0.058 | 0.079 | 0.143 | Glutamate dehydrogenase inhibitor | 0.143 0.017 CID_53463653 | CID_53463653 | |
| 0.032 | 0.055 | 0.104 | Antimetabolite | 0.104 0.016 CID_53463653 | CID_53463653 | |
| 0.005 | 0.034 | 0.027 | Purinergic P2Y agonist | 0.027 0.004 CID_53463653 | CID_53463653 | |
| 0.005 | 0.035 | 0.033 | Purinergic P2 agonist | 0.033 0.004 CID_53463653 | CID_53463653 | |
| 0.005 | 0.035 | 0.033 | Purinergic receptor agonist | 0.033 0.004 CID_53463653 | CID_53463653 | |
| 0.164 | 0.203 | 0.419 | Cholesterol antagonist | 0.419 0.046 CID_53463653 | CID_53463653 | |
| 0.033 | 0.075 | 0.079 | Acyl-CoA dehydrogenase inhibitor | 0.079 0.023 CID_53463653 | CID_53463653 | |
| 0.137 | 0.179 | 0.28 | Interleukin agonist | 0.28 0.059 CID_53463653 | CID_53463653 | |
| 0.077 | 0.12 | 0.131 | Mucolytic | 0.131 0.045 CID_53463653 | CID_53463653 | |
| 0.074 | 0.119 | 0.16 | Adenylate cyclase inhibitor | 0.16 0.039 CID_53463653 | CID_53463653 | |
| 0.012 | 0.063 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 CID_53463653 | CID_53463653 | |
| 0.017 | 0.073 | 0.027 | Purinergic P2Y15 antagonist | 0.027 0.022 CID_53463653 | CID_53463653 | |
| 0.163 | 0.221 | 0.395 | Vasodilator, coronary | 0.395 0.037 CID_53463653 | CID_53463653 | |
| 0.135 | 0.194 | 0.294 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.294 0.025 CID_53463653 | CID_53463653 | |
| 0.012 | 0.073 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.025 0.01 CID_53463653 | CID_53463653 | |
| 0.013 | 0.089 | 0.032 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 CID_53463653 | CID_53463653 | |
| 0.02 | 0.101 | 0.064 | Adenosine deaminase inhibitor | 0.064 0.017 CID_53463653 | CID_53463653 | |
| 0.148 | 0.23 | 0.273 | Transcription factor NF kappa B inhibitor | 0.273 0.111 CID_53463653 | CID_53463653 | |
| 0.116 | 0.199 | 0.176 | Phospholipase C inhibitor | 0.176 0.066 CID_53463653 | CID_53463653 | |
| 0.048 | 0.131 | 0.094 | Adenosine A3 receptor antagonist | 0.094 0.03 CID_53463653 | CID_53463653 | |
| 0.058 | 0.142 | 0.219 | Expectorant | 0.219 0.017 CID_53463653 | CID_53463653 | |
| 0.118 | 0.206 | 0.162 | Heat shock protein 70 antagonist | 0.162 0.025 CID_53463653 | CID_53463653 | |
| 0.079 | 0.171 | 0.205 | Cytidine deaminase inhibitor | 0.205 0.045 CID_53463653 | CID_53463653 | |
| 0.036 | 0.13 | 0.087 | Purinergic P2X1 antagonist | 0.087 0.021 CID_53463653 | CID_53463653 | |
| 0.031 | 0.129 | 0.051 | Heparanase inhibitor | 0.051 0.043 CID_53463653 | CID_53463653 | |
| 0.108 | 0.218 | 0.172 | Spasmolytic | 0.172 0.143 CID_53463653 | CID_53463653 | |
| 0.019 | 0.132 | 0.104 | Adenosine A1 receptor antagonist | 0.104 0.022 CID_53463653 | CID_53463653 | |
| 0.1 | 0.22 | 0.365 | Immunostimulant | 0.365 0.06 CID_53463653 | CID_53463653 | |
| 0.137 | 0.265 | 0.384 | Vasodilator, peripheral | 0.384 0.06 CID_53463653 | CID_53463653 | |
| 0.012 | 0.143 | 0.066 | Purinergic P2Y antagonist | 0.066 0.017 CID_53463653 | CID_53463653 | |
| 0.014 | 0.145 | 0.065 | Phosphorylase inhibitor | 0.065 0.022 CID_53463653 | CID_53463653 | |
| 0.081 | 0.214 | 0.17 | Hexokinase inhibitor | 0.17 0.057 CID_53463653 | CID_53463653 | |
| 0.055 | 0.193 | 0.097 | Alkylator | 0.097 0.092 CID_53463653 | CID_53463653 | |
| 0.152 | 0.292 | 0.288 | Interleukin 2 agonist | 0.288 0.083 CID_53463653 | CID_53463653 | |
| 0.007 | 0.162 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.015 CID_53463653 | CID_53463653 | |
| 0.008 | 0.175 | 0.035 | Phosphoglycerate kinase inhibitor | 0.035 0.025 CID_53463653 | CID_53463653 | |
| 0.034 | 0.208 | 0.08 | Adenine nucleotide translocase inhibitor | 0.08 0.009 CID_53463653 | CID_53463653 | |
| 0.004 | 0.186 | 0.016 | Adenosine A2 receptor agonist | 0.016 0.011 CID_53463653 | CID_53463653 | |
| 0.078 | 0.26 | 0.171 | Hypolipemic | 0.171 0.117 CID_53463653 | CID_53463653 | |
| 0.047 | 0.232 | 0.26 | DNA polymerase I inhibitor | 0.26 0.015 CID_53463653 | CID_53463653 | |
| 0.068 | 0.276 | 0.32 | DNA methyltransferase I inhibitor | 0.32 0.02 CID_53463653 | CID_53463653 | |
| 0.064 | 0.313 | 0.335 | DNA methylase inhibitor | 0.335 0.019 CID_53463653 | CID_53463653 | |
| 0.036 | 0.288 | 0.15 | AMP-activated protein kinase stimulant | 0.15 0.029 CID_53463653 | CID_53463653 | |
| 0.042 | 0.338 | 0.092 | Transcription factor NF kappa B stimulant | 0.092 0.048 CID_53463653 | CID_53463653 | |
| 0.08 | 0.378 | 0.331 | Immunosuppressant | 0.331 0.097 CID_53463653 | CID_53463653 | |
| 0.004 | 0.315 | 0.035 | Purinergic P2X agonist | 0.035 0.015 CID_53463653 | CID_53463653 | |
| 0.013 | 0.333 | 0.07 | Protein 50S ribosomal subunit inhibitor | 0.07 0.024 CID_53463653 | CID_53463653 | |
| 0.054 | 0.39 | 0.229 | Vasodilator | 0.229 0.083 CID_53463653 | CID_53463653 | |
| 0.005 | 0.348 | 0.024 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.024 0.011 CID_53463653 | CID_53463653 | |
| 0.054 | 0.398 | 0.156 | NOS3 expression enhancer | 0.156 0.067 CID_53463653 | CID_53463653 | |
| 0.024 | 0.396 | 0.219 | Cell adhesion molecule inhibitor | 0.219 0.008 CID_53463653 | CID_53463653 | |
| 0.071 | 0.476 | 0.308 | Antibacterial | 0.308 0.129 CID_53463653 | CID_53463653 | |
| 0.016 | 0.436 | 0.225 | Topoisomerase I inhibitor | 0.225 0.021 CID_53463653 | CID_53463653 | |
| 0.012 | 0.494 | 0.038 | Antibiotic Aminoglycoside-like | 0.038 0.023 CID_53463653 | CID_53463653 | |
| 0.027 | 0.516 | 0.263 | Cell adhesion inhibitor | 0.263 0.013 CID_53463653 | CID_53463653 | |
| 0.076 | 0.594 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.105 CID_53463653 | CID_53463653 | |
| 0.063 | 0.589 | 0.33 | Cyclophilin D inhibitor | 0.33 0.138 CID_53463653 | CID_53463653 | |
| 0.026 | 0.568 | 0.187 | Antioxidant | 0.187 0.125 CID_53463653 | CID_53463653 | |
| 0.019 | 0.572 | 0.366 | Angiogenesis stimulant | 0.366 0.028 CID_53463653 | CID_53463653 | |
| 0.035 | 0.611 | 0.212 | Hepatoprotectant | 0.212 0.058 CID_53463653 | CID_53463653 | |
| 0.013 | 0.608 | 0.094 | Uric acid excretion stimulant | 0.094 0.059 CID_53463653 | CID_53463653 | |
| 0.022 | 0.622 | 0.134 | Insulin secretagoues | 0.134 0.092 CID_53463653 | CID_53463653 | |
| 0.004 | 0.615 | 0.022 | Adenosine A3 receptor agonist | 0.022 0.008 CID_53463653 | CID_53463653 | |
| 0.005 | 0.62 | 0.072 | Selectin antagonist | 0.072 0.041 CID_53463653 | CID_53463653 | |
| 0.015 | 0.68 | 0.13 | Nitric oxide antagonist | 0.13 0.118 CID_53463653 | CID_53463653 | |
| 0.01 | 0.68 | 0.139 | Aminoacyl-tRNA synthetase inhibitor | 0.139 0.022 CID_53463653 | CID_53463653 | |
| 0.009 | 0.722 | 0.176 | Platelet antagonist | 0.176 0.12 CID_53463653 | CID_53463653 | |
| 0.033 | 0.751 | 0.317 | Antiinflammatory | 0.317 0.199 CID_53463653 | CID_53463653 | |
| 0.003 | 0.86 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.007 CID_53463653 | CID_53463653 | |
| 0.003 | 0.888 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.019 0.007 CID_53463653 | CID_53463653 | |
| 0.002 | 0.907 | 0.041 | Adenosine A1 receptor agonist | 0.041 0.007 CID_53463653 | CID_53463653 | |
| 0.008 | 0.919 | 0.19 | Platelet adhesion inhibitor | 0.19 0.077 CID_53463653 | CID_53463653 | |
| 0.007 | 0.939 | 0.177 | Hypoglycemic | 0.177 0.137 CID_53463653 | CID_53463653 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |